Romosozumab trials for Osteoporosis

All Romosozumab trials · All Osteoporosis trials

Phase breakdown

Recruiting trials studying Romosozumab for Osteoporosis

• A Study of Romosozumab in People With Breast Cancer and Osteoporosis
  NCT07776613 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 7 locations
• Combined Anabolic Therapy
  NCT06558188 · Phase: Phase 4 · Ages: 45 Years and older · Sex: Female · 1 location
• Romosozumab and Denosumab, Alone or Combined, in Postmenopausal Osteoporosis
  NCT07283887 · Phase: Phase 4 · Ages: 50 Years to 80 Years · Sex: Female · 1 location
• Sequential Therapies After Osteoanabolic Treatment
  NCT06164795 · Phase: Not specified · Ages: 50 Years to 85 Years · Sex: Female · 8 locations
• The Optimised Use of Romozosumab Study
  NCT06059222 · Phase: Phase 4 · Ages: 50 Years and older · Sex: Female · 1 location

Common questions

How many trials study Romosozumab for Osteoporosis?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.